TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global automated drug compounding systems market was valued at US$ 1.61 billion in 2023 and is projected to reach US$ 2.67 billion by 2030, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
An automated compounding system is a device that combines one or more drug solutions to a final container for patient administration. Automated compounding system helps avoid medication error that occurs due to a variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion while using similar labels. However, with the automated compounding systems, the accuracy and efficiency of dispensing compounded products have improved and reduced the exposure of healthcare professionals to toxic agents.
This report aims to provide a comprehensive presentation of the global market for Automated Drug Compounding Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Drug Compounding Systems. This report contains market size and forecasts of Automated Drug Compounding Systems in global, including the following market information:
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Gravimetric Automated Compounding Systems Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Automated Drug Compounding Systems include Baxter International Inc., Braun Melsungen AG, Comecer, ICU MEDICAL INC, Grifols, S.A., Omnicell, Equashield, ARxIUM and Weibond Technology, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Automated Drug Compounding Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Automated Drug Compounding Systems Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Automated Drug Compounding Systems Market Segment Percentages, by Type, 2023 (%)
Global Automated Drug Compounding Systems Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Automated Drug Compounding Systems Market Segment Percentages, by Application, 2023 (%)
Global Automated Drug Compounding Systems Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Automated Drug Compounding Systems Market Segment Percentages, By Region and Country, 2023 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Outline of Major Chapters:
Chapter 1: Introduces the definition of Automated Drug Compounding Systems, market overview.
Chapter 2: Global Automated Drug Compounding Systems market size in revenue and volume.
Chapter 3: Detailed analysis of Automated Drug Compounding Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Automated Drug Compounding Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Automated Drug Compounding Systems capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
